F

FRX

Fennec Pharms

9.04

0.000.00%

Closed09:30 05/09 EDT

1D

5D

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE--/9.04

TODAY RANGE-

VOL--

MARKET CAP249.49M

52 WEEK RANGE5.65-13.72

AVG VOL (3M)583

% TURNOVER0%

TURNOVER--

P/E (TTM)-393.0435

% RANGE--

EPS(TTM)-0.0230

P/E(FORWARD)69.54

P/B-29.5328

BVPS-0.3061

DIVIDEND--

P/S3.648

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP206.84M

SHARES OUTSTANDING27.60M

NEXT EARNINGS--

FREE FLOAT22.88M

LOT SIZE100

EX-DIV DATE09/05/2014

News

Press Releases

Financial Reports

Profile

Dow Jones·03/11 11:02
Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by HC Wainwright & Co.
Dow Jones·03/10 19:37
Fennec Pharmaceuticals Shares Down After 4Q Results
Dow Jones·03/10 10:03
*Fennec Pharmaceuticals 4Q Rev $7.93M >FRX.T
Dow Jones·03/10 10:03
*Fennec Pharmaceuticals 4Q Loss/Shr 6c >FRX.T
Dow Jones·03/10 10:03
*Fennec Pharmaceuticals 4Q Loss $1.62M >FRX.T
Dow Jones·11/07/2024 11:13
*Fennec Pharmaceuticals 3Q Loss $5.74M >FRX.T
Dow Jones·11/07/2024 11:13
*Fennec Pharmaceuticals 3Q Loss/Shr 21c >FRX.T
Dow Jones·08/22/2024 13:17
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·08/22/2024 13:17
Fennec Pharmaceuticals Price Target Cut to $13.00/Share From $15.00 by HC Wainwright & Co.
Dow Jones·08/14/2024 12:56
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Dow Jones·08/14/2024 12:56
Fennec Pharmaceuticals Price Target Cut to $15.00/Share From $17.00 by Craig-Hallum
Dow Jones·08/13/2024 10:06
*Fennec Pharmaceuticals 2Q Loss/Shr 20c >FRX.T
Dow Jones·08/13/2024 10:05
*Fennec Pharmaceuticals 2Q Rev $7.26M >FRX.T
Dow Jones·08/05/2024 10:26
*Fennec Pharmaceuticals Appoints Jeffrey Hackman as CEO and Director >FENC
Dow Jones·05/15/2024 18:03
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others